Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial.
Clin Cardiol
; 46(7): 777-784, 2023 Jul.
Article
in En
| MEDLINE
| ID: mdl-37191146
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atrial Fibrillation
/
Acute Coronary Syndrome
/
Drug-Eluting Stents
/
Percutaneous Coronary Intervention
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Clin Cardiol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: